Telemedicine for Additional Diagnosis

Information Science and Engineering

NATIONAL CONFERENCE on VLSI, COMMUNICATION AND SIGNAL PROCESSING (NCVCS-2017)

Many organizations in India have been lately involved in developing and deploying various Healthcare based initiatives to make healthcare more accessible and affordable. Telemedicine for Additional Diagnosis (TAD) is another such initiative. It aims to make better healthcare assistance available to people in all parts of the country with limited local healthcare. It helps in collaborating with multiple super specialty hospitals to bring their healthcare experts onboard this platform. TAD is to help the people deal with the very common scenario encountered when going through some medical condition. Many a times, when suffering through a medical condition, there seems to be no relief from it. The condition seems to prolong even after medication prescribed from the local doctor. This generally happens due to the misdiagnosis of the underlying condition or hasty judgments made by the local doctor, inexperience of the doctor or just due to the lack of the relevant data. On many occasions the doctor may also suggest some invasive procedure which may turn out to be expensive and leave lasting side effects. In such situations, what normally people tend to do is to approach another doctor for an additional opinion on the diagnosis provided by the previous doctor. The doctor re-examines the patient along with the details provided by the previous doctor and suggests an alternative track of treatment or corroborates what the first doctor had already said. Our aim is to assist this additional opinion. Generally, the second opinion doctor tend to be selected based on word of mouth. It becomes especially hard to find such a doctor in smaller tier-2 and tier-3 cities. That’s where our platform comes into picture. To provide a medium to connect people in any part of the country to healthcare experts to gain an additional diagnosis.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.